Article Details
Retrieved on: 2024-06-01 12:18:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
NON-REGULATORY PRESS RELEASE Oslo, June 1, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing ...
Article found on: kommunikasjon.ntb.no
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here